MedTrace Logo

Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison

NCT00626366 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2023-09-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the distribution of nasal sprays and nasal drops when used.

Conditions

  • Chronic Sinusitis

Interventions

RADIATION

Sinus CT Scan

Subjects will undergo a Xoran miniCAT scan of their sinuses

DRUG

Omnipaque 240 Contrast Solution

Subjects will spray 2-4 drops of half-strength Omnipaque 240 mgI/mL into each nare. Each spray is approximately 0.1 ml.

DRUG

Omnipaque 240 mg I/mL

Subjects will place two drops of half-strength Omnipaque 240 mg I/mL intranasally to each nose. Each drop is approximately 1 ml.

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Erin K O'Brien, MD · University of Nebraska

  • Donald Leopold, MD · University of Nebraska

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-12
Primary Completion
2009-01-09
Completion
2009-01-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00626366 on ClinicalTrials.gov